Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study

Published:2023-12-22 Issue: Volume: Page:
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zhou Yi-Xin¹,Wang Jia-Ling¹,Mu Xiao-Li¹,Zhu Ya-Juan¹,Chen Ye²,Liu Ji-Yan¹

Affiliation:

1. Department of Biotherapy, Cancer Centre, West China Hospital, Sichuan University, Chengdu, China

2. Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference36 articles.

1. Untangling the ErbB signalling network.;Sliwkowski;Nat Rev Mol Cell Biol,2001

2. Breast cancer.;Gnant;Lancet,2017

3. Current treatment and recent progress in gastric cancer.;Badgwell;CA Cancer J Clin,2021

4. Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions.;Ali;BJU Int,2020

5. Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.;Trusolino;Ann Oncol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP